Cargando…

Vasoactive intestinal peptide alleviates osteoarthritis effectively via inhibiting NF-κB signaling pathway

BACKGROUND: To investigate the treatment effect of vasoactive intestinal peptide (VIP) on osteoarthritis (OA) and the relative mechanism. METHOD: The OA model on the SD rat knee was established using the modified Hulth method, and the recombinant pcDNA3.1+/VIP plasmid was constructed. One month afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Yaozhong, Chen, Shu, Yang, Yuhao, Lan, Chunhai, Zhang, Guowei, Ji, Zhisheng, Lin, Hongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851098/ https://www.ncbi.nlm.nih.gov/pubmed/29540226 http://dx.doi.org/10.1186/s12929-018-0410-z

Ejemplares similares

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

Electroacupuncture Inhibits Inflammation Reaction by Upregulating Vasoactive Intestinal Peptide in Rats with Adjuvant-Induced Arthritis
por: He, Tian-Feng, et al.
Publicado: (2011)

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
por: Hermel, Melody, et al.
Publicado: (2021)

Vasoactive intestinal peptide inhibits the production of Salmonella-induced inflammatory cytokines by human monocytes
por: Askar, B, et al.
Publicado: (2014)

Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
por: Chaudhury, Dipesh, et al.
Publicado: (2008)

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
Publicado: (1987)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
por: Belei, Oana, et al.
Publicado: (2023)

Salidroside Alleviates Cartilage Degeneration Through NF-κB Pathway in Osteoarthritis Rats
por: Gao, Hui, et al.
Publicado: (2020)

Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats
por: Xu, Chun-Lan, et al.
Publicado: (2018)

Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
por: Li, Bo, et al.
Publicado: (2019)

Vasoactive intestinal peptide regulates ileal goblet cell production in mice
por: Schwerdtfeger, Luke A., et al.
Publicado: (2020)

Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
por: Ataallah, Basma, et al.
Publicado: (2020)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
por: Isaka, Mitsuhiro, et al.
Publicado: (2021)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
por: Privalov, Evgeny, et al.
Publicado: (2023)

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility
por: Nassif, A., et al.
Publicado: (1995)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
por: Wu, Dongmei, et al.
Publicado: (2011)

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis
por: Martínez, Carmen, et al.
Publicado: (2014)

Role of Vasoactive Intestinal Peptide in Promoting the Pathogenesis of Eosinophilic Esophagitis (EoE)
por: Verma, Alok K., et al.
Publicado: (2017)

Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception
por: Zhu, Zhen-chuang, et al.
Publicado: (2019)

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system
por: Iwasaki, Mari, et al.
Publicado: (2019)

Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report
por: Thivacaren, Sritharan, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature
por: Yee, Shelby K., et al.
Publicado: (2022)

Vasoactive intestinal peptide–VIPR2 signaling regulates tumor cell migration
por: Asano, Satoshi, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge
por: Lopes, Sara, et al.
Publicado: (2022)

Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF-κB Pathway
por: Li, Sunlong, et al.
Publicado: (2022)

Dendrobine Alleviates Cellular Senescence and Osteoarthritis via the ROS/NF-κB Axis
por: Chen, Haitao, et al.
Publicado: (2023)

Intracerebroventricular Infusion of Vasoactive Intestinal Peptide Rescues the Luteinizing Hormone Surge in Middle-Aged Female Rats
por: Sun, Yan, et al.
Publicado: (2012)

Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl‐xL pathway
por: Hara, Masaki, et al.
Publicado: (2018)

Rat Cerebellar Grafts Have (125)I-Vasoactive Intestinal Peptide Binding Sites
por: Moody, T. W., et al.
Publicado: (1992)

123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.
por: Raderer, M., et al.
Publicado: (1998)

In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells
Publicado: (1984)

Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome
por: Goff, Kevin M, et al.
Publicado: (2019)

Neuropeptide immunofluorescence in human nasal mucosa: assessment of the technique for vasoactive intestinal peptide (VIP)
por: de Mendonça, Jeferson Cedaro, et al.
Publicado: (2015)

Yao Syndrome: A Potential Role and Association of Vasoactive Intestinal Peptide with NOD2
por: Navetta-Modrov, Brianne, et al.
Publicado: (2021)

Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery
por: Kang, Yang, et al.
Publicado: (2023)

THU262 Improvement Of Pharmacokinetic Properties Of Vasoactive Intestinal Peptide Through Backbone Modifications
por: Al Najar, Mathew S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_krovneqcjvv25618sml3qi41va